Wikidata

(Q61909897)

English

A Dose Finding Study to Assess the Effect of LIK066 Compared to Placebo or Empagliflozin in Patients With Type 2 Diabetes Mellitus and Heart Failure

clinical trial

In more languages

Statements

title
A Multi-center, Randomized, Double-blind, Parallel-group Dose-finding Study to Assess the Effect of 3 Doses of LIK066 Compared to Placebo or Empagliflozin in Type 2 Diabetes Mellitus Patients With Heart Failure (English)
0 references
medical condition
diabetes
0 references
heart failure
0 references
sponsor
Novartis
0 references
country
Argentina
0 references
Austria
0 references
Belgium
0 references
Bulgaria
0 references
Canada
0 references
Croatia
0 references
Denmark
0 references
Germany
0 references
Hungary
0 references
Republic of Ireland
0 references
Italy
0 references
Mexico
0 references
Netherlands
0 references
Norway
0 references
Poland
0 references
Singapore
0 references
South Africa
0 references
Spain
0 references
Taiwan
0 references
United Kingdom
0 references
start time
25 July 2017
0 references
end time
6 June 2018
0 references
number of participants
125
0 references
research site
Novartis
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61909897&oldid=2104276592"